Related Experiment Video

Updated: Jun 8, 2026

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

Cardiac assessment in duchenne and becker muscular dystrophies

Anitra Romfh1, Elizabeth M McNally

  • 1Section of Cardiology, Department of Medicine, The University of Chicago, 5841 South Maryland Avenue, MC6088, Chicago, IL 60637, USA.

Current Heart Failure Reports
|September 22, 2010
PubMed

Insights

Duchenne and Becker muscular dystrophies, caused by dystrophin gene mutations, often involve cardiomyopathy. This review focuses on cardiac care guidelines for advanced Duchenne and Becker muscular dystrophy patients.

Area of Science:

  • Cardiology
  • Genetics
  • Neuromuscular Disorders

Background:

  • Duchenne and Becker muscular dystrophies result from dystrophin gene mutations.
  • Cardiomyopathy is a common comorbidity, often independent of skeletal muscle disease severity.
  • Cardiac dysfunction includes four-chamber dilation, reduced left ventricular function, and life-threatening arrhythmias.

Purpose of the Study:

  • To review current care guidelines for Duchenne muscular dystrophy.
  • To provide recommendations for monitoring and treating cardiac disease in advanced Duchenne and Becker muscular dystrophies.

Main Methods:

  • Review of existing care guidelines.
  • Synthesis of recommendations for cardiac disease management.
  • Focus on surveillance and treatment strategies.

Main Results:

  • Established care guidelines exist for younger Duchenne muscular dystrophy patients.
  • Recommendations are provided for managing cardiac complications in advanced stages.
  • Cardiac function is influenced by respiratory function in these dystrophies.

Conclusions:

  • Cardiac monitoring and treatment are crucial for patients with Duchenne and Becker muscular dystrophies.
  • Guidelines should be adapted for advanced disease stages.
  • Multidisciplinary care is essential for optimal patient outcomes.

More Related Videos

Assessing Functional Performance in the Mdx Mouse Model10:32

Assessing Functional Performance in the Mdx Mouse Model

Published on: March 27, 2014

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies14:10

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies

Published on: January 31, 2013

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...